EMEA-002018-PIP02-16-M05
Key facts
Invented name |
Venclyxto
|
Active substance |
Venetoclax
|
Therapeutic area |
|
Decision number |
P/0148/2022
|
PIP number |
EMEA-002018-PIP02-16-M05
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
AbbVie Ltd
E-mail: paediatricteam@abbvie.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|